Lilly to Sell Obesity Drugs Directly on Hims & Hers Site
Eli Lilly struck a deal allowing Hims & Hers Health to sell Zepbound and Foundayo directly on its platform. The drugs were previously available there only if patients left the site.
Story updates
11:47:26 AM UTC
SquawkNews
Lilly and Hims & Hers agreed to offer eligible patients with prescriptions access to Zepbound and Foundayo through the Hims & Hers platform. Self-pay prices start at $149 per month for Foundayo and $299 per month for Zepbound; no prior-period comparison was provided.Material DetailsContext by AI An…
By Michael ErmanEli Lilly NYSE:LLY said on Friday that it struck a deal to allow telehealth company Hims & Hers Health NYSE:HIMS to sell obesity drugs Zepbound and Foundayo directly on its platform.The Lilly drugs were previously available to patients on Hims & Hers only if they left the site and w…